New Jersey-based biopharmaceutical company Palatin Technologies is entering into Phase III trials of their new product, Bremelanotide, which addresses the issue of sexual dysfunction. Unlike Viagra and its cousins, this chemical is not a penile blood flow booster, but it deals with the bigger sex organ—your noggin. Consequently, it will also work on women who suffer from similar intimacy problems.

Essentially, it triggers the sexual light switch in your brains. Because those receptors are the same for both men and women, both of you can share the same nasal inhaler and expect similar results.

Aphrodisiacs – Are They Out There? [newstoob.com]